What amount sold does Hera Testing Laboratories, Inc. report in Form D filings?

The latest linked filings report $3.4M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Hera Testing Laboratories, Inc.'s most recent SEC filing?

Hera Testing Laboratories, Inc.'s most recent Form D filing was on 2020-08-04.

How many investors does Hera Testing Laboratories, Inc. have?

The most recent Form D filing lists 9 investor(s).

What type of securities does Hera Testing Laboratories, Inc. offer?

Hera Testing Laboratories, Inc.'s SEC Form D filings indicate equity offerings.

Hera Testing Laboratories, Inc.

CIK: 0001634989·Biotechnology·LEXINGTON, KY·Corporation

Reported Sold

$3,393,569

Total Filings

Identified Offerings

Last Filed

Aug 4, 2020

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Aug 4, 2020Form D — New notice

Reported sold: $1,068,569 · Target: $1,068,569

Rule 506(b)·9 investors

Apr 25, 2018Form D — New notice

Reported sold: $525,000 · Target: $1,000,000

Rule 506(b)·8 investors

Sep 26, 2016Form D — New notice

Reported sold: $700,000 · Target: $1,000,000

Rule 506(b)·7 investors

Feb 25, 2015Form D — New notice

Reported sold: $1,100,000 · Target: $2,000,000

Rule 506(b)·15 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 4 identified offerings

$3,393,569

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Eric M Ostertag

Related Person

Appears on 3 filings

Jack Crawford

Related Person

Appears on 2 filings

Christopher Young

Related Person

Appears on 2 filings

Michael J Schlosser

Related Person

Appears on 1 filing

Michael J. Schlosser

Related Person

Appears on 1 filing

Eric Ostertag

Related Person

Appears on 1 filing

Christopher H. Young

Related Person

Appears on 1 filing

Thomas Isett

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 4, 2020	New	$1,068,569	$1,068,569	9
Apr 25, 2018	New	$1,000,000	$525,000	8
Sep 26, 2016	New	$1,000,000	$700,000	7
Feb 25, 2015	New	$2,000,000	$1,100,000	15

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

511 Therapeutics, Inc.

Biotechnology

Offering target: $1,000,000

Filed Oct 30, 2026